eScholarship
metadata only
Immunomodulation of the CD200 axis protects Microglia from Alzheimer’s Disease-induced Damage
Alzheimer’s Disease (AD) is the most prevalent form of dementia and a leading cause of death. Disease hallmarks include chronic neuroinflammation and impaired clearance of toxic protein aggregates. We use exogenous CD200 to polarize microglia towards a state that measurably dampens inflammation and
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- The Effect of Celecoxib on Neuroinflammation in MDD#840306
- Key targets and mechanisms by which gut microbiota-derived metabolites regulate Alzheimer’s disease through the immune - inflammatory pathway: Based on network pharmacology and molecular docking#345382
- 9-month Study to Assess the Efficacy of Ofatumumab on Microglia in Patients With Relapsing Forms of Multiple Sclerosis#850391
- GLP-1 Analogue in Preventing Progression of Small Vessel Disease (GAPP-SVD)#967676
- Assessment of Foralumab Safety and Modulation of Microglial Activation in Alzheimer's Disease#1153050
Record · ID 1065592
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive